Acuta Capital Partners, LLC Aadi Bioscience, Inc. Transaction History
Acuta Capital Partners, LLC
- $53.1 Million
- Q3 2025
A detailed history of Acuta Capital Partners, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 3,410,402 shares of AADI stock, worth $5.83 Million. This represents 10.98% of its overall portfolio holdings.
Number of Shares
3,410,402
Previous 3,410,402
-0.0%
Holding current value
$5.83 Million
Previous $5.83 Million
-0.0%
% of portfolio
10.98%
Previous 14.49%
Shares
3 transactions
Others Institutions Holding AADI
# of Institutions
44Shares Held
29.4MCall Options Held
0Put Options Held
0-
Qvt Financial LP New York, NY4.62MShares$7.89 Million0.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.17MShares$7.12 Million0.24% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.7MShares$6.33 Million0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.85MShares$4.87 Million0.07% of portfolio
-
Siren, L.L.C. New York, NY2.08MShares$3.56 Million0.15% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $35.9M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...